SCHEMBL12295377

SCHEMBL12295377

Cc1ccc2c(c1)C(c1cccc(C(F)(F)F)c1)(c1cccc(C(F)(F)F)c1)c1cc(C)ccc1-2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 5/20 0.45
KDM1A O60341 2/20 0.43
NFE2L2 Q16236 1/20 0.43
SLC6A4 P31645 3/20 0.40
SLC6A3 Q01959 2/20 0.40
SLC6A2 P23975 1/20 0.40
RAPGEF4 Q8WZA2 1/20 0.38
FFAR1 O14842 1/20 0.38
CDK1 P06493 1/20 0.38
CCNB1 P14635 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK2 P24941 1/20 0.38
CDK7 P50613 1/20 0.38
CCNH P51946 1/20 0.38
CCNA1 P78396 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
KIF11 P52732 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13779201 0.85 PDK2 (0.45) PDK2NFE2L2RAPGEF4KIF11
SCHEMBL13779200 0.82 PDK2 (0.45) PDK2KDM1AKIF11
SCHEMBL25629530 0.81 PDK2 (0.46) PDK2KIF11MEN1KMT2ATSHR
SCHEMBL16167859 0.79 PDK2 (0.43) PDK2KDM1AKIF11
SCHEMBL25473944 0.76 PDK2 (0.47) PDK2MEN1KMT2ATSHRRAB9A
SCHEMBL19286967 0.76 ACHE (0.48) PDK2RAPGEF4
SCHEMBL17666355 0.75 ESR1 (0.47) PDK2KDM1ASLC6A4SLC6A3SLC6A2
SCHEMBL12374340 0.73 ACHE (0.52) PDK2KDM1ASLC6A3SLC6A2KMT2A
SCHEMBL14330031 0.73 PDK2 (0.43) PDK2NFE2L2RAPGEF4KIF11
SCHEMBL21258346 0.73 NPSR1 (0.48) PDK2KIF11MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2363423-A1 9-aryl and bisaryl subtituted polyfluorenes CAMBRIDGE DISPLAY TECHNOLOGY LTD. (GB) 2011-09-07 EP disclosed
US-20090167170-A1 Polymer CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-07-02 US disclosed
US-20090167170-A1 Polymer CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-07-02 US disclosed
US-7494720-B2 9-aryl and bisaryl substituted polyfluorenes CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-02-24 US disclosed
US-7494720-B2 9-aryl and bisaryl substituted polyfluorenes CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2009-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090167170-A1 Polymer AHR, PARG, PARN PDK2 2277/4885KDM1A 404/4885NFE2L2 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.